Alpha-methylacyl-CoA-racemase (AMACR) deficiency (MIM#604489) is a peroxisomal disorder resulting in the accumulation of pristanic acid, dihydroxycholestanoic acid (DHCA), and trihydroxycholestanoic acid (THCA), with variable clinical features and age of onset from infancy to late adulthood. The purpose of this report is to define clinical variations and follow-up data in AMACR deficiency emphasizing treatment with a review of cases reported in the literature. Here, four patients, from two families, diagnosed with AMACR deficiency and showing phenotypic heterogeneity are presented. A 10-month-old-female presented with coagulopathy, hepatic dysfunction, and elevated pristanic acid, DHCA, and THCA levels. Genetic testing confirmed a homozygous variant c.596G>A in the gene. Her brother who had macrovesicular hepatosteatosis and elevated pristanic acid levels was diagnosed with family screening. The third patient presented with rhabdomyolysis following a strenuous exercise without any other complaint. Homozygous novel c.1006G>A variant was found on the gene. His asymptomatic sister carrying the same variant also had elevated pristanic acid levels. They had normal neuropsychologic evaluation. Dietary treatment with low phytanic and pristanic acid content was recommended to the patients but all showed poor compliance. The sibling pairs were followed for periods of 11 and 7 years, respectively. AMACR deficiency is usually described as an adult-onset disorder with neuropsychological problems. The characterization of natural history and new clinical phenotypes may support earlier diagnosis and treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558467PMC
http://dx.doi.org/10.1002/jmd2.12437DOI Listing

Publication Analysis

Top Keywords

pristanic acid
20
amacr deficiency
16
elevated pristanic
12
variable clinical
8
clinical phenotypes
8
acid dhca
8
acid levels
8
acid
7
deficiency
5
pristanic
5

Similar Publications

Alpha-methylacyl-CoA-racemase (AMACR) deficiency (MIM#604489) is a peroxisomal disorder resulting in the accumulation of pristanic acid, dihydroxycholestanoic acid (DHCA), and trihydroxycholestanoic acid (THCA), with variable clinical features and age of onset from infancy to late adulthood. The purpose of this report is to define clinical variations and follow-up data in AMACR deficiency emphasizing treatment with a review of cases reported in the literature. Here, four patients, from two families, diagnosed with AMACR deficiency and showing phenotypic heterogeneity are presented.

View Article and Find Full Text PDF

Morphomics, Survival, and Metabolites in Patients With Metastatic Pancreatic Cancer.

JAMA Netw Open

October 2024

Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor.

Article Synopsis
  • - This study explores how Body Mass Index (BMI) and body composition (morphomics) relate to survival rates in patients with metastatic pancreatic ductal adenocarcinoma (PDA), highlighting variability in previous research.
  • - Conducted during a phase 3 clinical trial involving 528 patients across multiple countries, the study collected extensive patient data and used imaging to analyze body composition and serum metabolites for better survival predictions.
  • - Findings showed that higher BMI (specifically obesity) wasn't linked to overall survival, while an increase in subcutaneous fat was associated with better outcomes, indicating that factors beyond BMI, like body composition, may play a crucial role in patient survival.
View Article and Find Full Text PDF

Redefining the phenotype of alpha-methylacyl-CoA racemase (AMACR) deficiency.

Orphanet J Rare Dis

September 2024

Department of Pediatric Neurology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam Leukodystrophy Center, Amsterdam, The Netherlands.

Article Synopsis
  • Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare genetic disorder that causes the buildup of toxic bile acids and has been minimally studied, with fewer than 20 documented cases.
  • A recent study involving 12 patients revealed that symptoms like retinitis pigmentosa and neurological issues typically develop in adults after a significant delay in diagnosis, with a median age of 56 years at the time of identification.
  • The condition presents primarily as a slowly progressive neurological disease, and MRI scans can help identify characteristic brain abnormalities, highlighting the need for better recognition and awareness of AMACR deficiency.
View Article and Find Full Text PDF

Phytanic acid (PA) (3,7,11,15-tetramethylhexadecanoic acid) is a methyl-branched fatty acid that enters the body through food consumption, primarily through red meat, dairy products, and fatty marine foods. The metabolic byproduct of phytol is PA, which is then oxidized by the ruminal microbiota and some marine species. The first methyl group at the 3-position prevents the β-oxidation of branched-chain fatty acid (BCFA).

View Article and Find Full Text PDF

Background: Zellweger spectrum disorder (ZSD) (OMIM#214100) is a phenotypic continuum ranging from severe to mild presentations. ZSD is now used in all individuals with a defect in one of the 13 ZSD-PEX genes, regardless of phenotype. Diagnosis can be suggested by abnormal levels of very long-chain fatty acids, phytanic acid, pristanic acid, plasmalogens, pipecolic acid, or bile acids.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!